SCIESCOPUSQ1
CANCER IMMUNOLOGY IMMUNOTHERAPY
SPRINGER, Germany
CANCER IMMUNOLOGY IMMUNOTHERAPY is an academic journal published by SPRINGER (Germany). Identifiers: ISSN 0340-7004, eISSN 1432-0851. Indexed in SCIE, SCOPUS. Metrics: JIF 5.1, CiteScore 10.7, SJR 1.716, SNIP 0.99. Subject areas: IMMUNOLOGY, ONCOLOGY. tlooto lists 6,518 papers from this journal.
CiteScore
10.70
Scopus citation metric
SJR
1.716
SCImago rank
SNIP
0.99
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 0340-7004
- eISSN
- 1432-0851
- Abbreviation
- CANCER IMMUNOL IMMUN
- Publisher
- SPRINGER
- Country
- Germany
Web of Science categories
SCIEIMMUNOLOGY, ONCOLOGY
Scopus ASJC categories
1306 Cancer Research2403 Immunology2723 Immunology and Allergy2730 Oncology
Keywords
Oncology | Immunology
Papers in this journal
Recent papers
- Rosuvastatin enhances the efficacy of venetoclax-azacitidine in older acute myeloid leukemia patients via reducing T-cell exhaustion
2026
- CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect
2026
- Comparative efficacy of combination regimens based on interventional therapy and immune checkpoint inhibitors (ICIs) in patients with intermediate- and advanced-stage hepatocellular carcinoma: a systematic review, meta-analysis, and network meta-analysis
2026 · 1 citations
- AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 study
2026
- NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.
2026
Most cited papers
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
2008 · 1,279 citations
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
2007 · 1,273 citations
- A listing of human tumor antigens recognized by T cells
2001 · 810 citations
- An immune-active tumor microenvironment favors clinical response to ipilimumab
2012 · 724 citations
- Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
2005 · 676 citations